{"id":"W2048013288","doi":"10.1016/j.jpba.2007.12.025","title":"Development of a discriminating in vitro dissolution method for a poorly soluble NO-donating selective cyclooxygenase-2 inhibitor","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Merck Canada Inc. (Canada); TransCanada (Canada)","funders":"","keywords":"Chemistry; Dissolution; Chromatography; Bioavailability; Solubility; Particle size; Dissolution testing; Dosage form; Pulmonary surfactant; In vivo; Granule (geology); High-performance liquid chromatography; Pharmacokinetics; Pharmacology; Biopharmaceutics Classification System; Biochemistry; Organic chemistry; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007133462,0.0006650992,0.00047774,0.0002767407,0.0002885995,0.0003246088,0.0004588176,0.0004827123,0.0006365175],"category_scores_gemma":[0.0008358279,0.0003727629,0.0002674249,0.0001331673,0.0002513075,0.0003263882,0.0002895084,0.0008556034,0.0004466431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003157712,"about_ca_system_score_gemma":0.0005431175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001018752,"about_ca_topic_score_gemma":0.002880718,"domain_scores_codex":[0.9995701,0.0001197363,0.0000370817,0.0000972456,0.0001393856,0.00003650294],"domain_scores_gemma":[0.9995085,0.0001899197,0.0001116446,0.00004293751,0.0001011217,0.00004584705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0000373142,0.00001617835,0.00005718966,0.00002777567,0.000003688329,0.00001914715,0.000006934275,0.0000371123,0.9977642,0.00006370853,0.00002934361,0.001937333],"study_design_scores_gemma":[0.000009172319,0.0001073625,0.0005146605,0.000003216555,0.00001527508,0.0001671783,0.000006302581,0.001155891,0.9964234,0.00001777397,0.00157368,0.000006074501],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5089894,0.005296216,0.478271,0.0006130283,0.0003275836,0.0007496038,0.0006099993,0.0004470581,0.004696131],"genre_scores_gemma":[0.6740872,0.003791057,0.3077357,0.0002994788,0.0001182031,0.0005036803,0.001240398,0.0001490386,0.01207533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001018752,"threshold_uncertainty_score":0.003772616,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08266611607901135,"score_gpt":0.451466959442713,"score_spread":0.3688008433637017,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}